Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis

Abstract

The prevalence of lupus anticoagulant (LA) and antiphospholipid antibodies (APA) in young patients (<45 years) with deep-vein thrombosis (DVT) is not clearly defined yet. We studied 93 consecutive patients (36 males, 57 females; aged 15 to 45) with objectively documented DVT. A control group consisting of 100 nor mal, sex- and age-matched individuals was also investi gated. In all subjects, we evaluated prothrombin time (PT), partial thromboplastin time (PTT), AT III antigen and activity, protein C antigen and activity, free and total protein S antigen and protein S activity, fibrinogen, plas minogen, heparin cofactor II, plasminogen activator in hibitor (PAI), lupus anticoagulant (LA), and APA. For the assessment of LA, we used the PTT-LA kit (Boeh ringer Mannheim, Milan, Italy) as a screening test, with mixing studies with the Staclot-PNP kit and the Staclot- LA kit (Boehringer Mannheim, Milan, Italy) as confirma tory procedures. For the detection of APA, we used a commercially available enzyme-linked immunoassay (ELISA) (Asserachrom APA, Boehringer Mannheim, Mi lan, Italy). History was elicited in all patients to deter mine if the thrombotic episode was idiopathic or the re sult of a well-identified risk factor. LA was found in 11 (11.8%) patients. APA were positive in 13 (14%) and bor derline in 19 (20.4%) patients. In the control group, no patients were positive for LA or APA, but five exhibited borderline APA levels. LA was significantly more fre quent (p = 0.05) in patients with idiopathic DVT than in patients with secondary DVT; no difference was found for APA (p > 0.5). An inherited coagulation defect was found in seven (7.5%) patients. Our data suggest that the presence of LA or APA is associated with an increased incidence of thrombotic manifestation in young patients. Moreover LA is more frequent in patients with idiopathic DVT. Because the incidence of recurrent thrombotic manifestations in patients with LA or APA is estimated to be ∼50% within 2 years from the first thrombotic episode, the tests should be performed in all patients with juvenile thrombosis.

Keywords

Key Words: Lupus anticoagulant Antiphospholipid antibodies Deep-vein thrombosis.

Get full access to this article

View all access options for this article.

References

Feinstein DI , Rapaport SI Acquired inhibitors of blood coagulation . Prog Hemost Thromb 1972;1:75.

Loizou S. , McCrea JD , Rudge AC , et al. Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1986;62:738.

Shi W. , Krilis SA , Chon BH , et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990 ;20:231.

Bowie Ejw , Thompson JM , Pascuzzi PA , et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;162:417.

Boey ML , Colaco CB , Gharavi AE , et al. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287:1021.

Elias M. , Eldor A. Thromboembolism in patients with the lupus type circulating anticoagulant . Arch Intern Med 1984; 144:510.

Glueck HI , Kant KS , Weiss MA , et al. Thrombosis in systemic lupus erythematosus. Arch Intern Med 1985;145:1389.

Kornberg A. , Silber L. , Yona R. , et al. Clinical manifestations and laboratory findings in patients with lupus anticoagulants. Eur J Haematol 1989;42:90.

Feinstein DI Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992;80:859.

10.

Ryan P. , Street A. Thrombosis and antiphospholipid antibodies—an evolving story . Aust NZ J Med 1993;23:148-50.

11.

Bick RL , Baker WF

Anticardiolipin antibodies and thrombosis

Hematol Oncol Clin North Am 1992;6:1287.

12.

Manoharan A. , Gibson L. , Ruch B. , et al. Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus. Aust NZ J Med 1977;7:422.

13.

Asherson RA A primary antiphospholipid syndrome. J Rheumatol 1988;15:1742.

14.

Lechner K. , Pabinger-Fasching I. Lupus anticoagulant and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985;15:254.

15.

Kapiotis S. , Speiser W. , Pabinger-Fasching I. , et al. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 1991;21:19.

16.

Palareti G. , Legnani C. , Ludovici S. , et al. Prevalence of high levels of antiphospholipid antibodies in otherwise unexplained juvenile venous thromboembolism. Thromb Haemost 1991 ;65:452.

17.

Bentolila S. , Horellou MH , Conard J. , et al. Prevalence of anticardiolipin antibodies in patients with a history of deep venous thrombosis (DVT). Haemostasis 1994;24(suppl 1) 137.

18.

Fijnheer R. , de Valk B. , Punt J. , et al. Antiphospholipid antibodies in patients with thrombo-embolic disease: a prospective, controlled study. Br J Haematol 1994;87(suppl 1): 180.

19.

Stegnar M. , Bozic B. , Peternel P. , et al. Prevalence of antiphospholipid antibodies in deep vein thrombosis . Thromb Haemost 1991;65:1005.

20.

O'Donnel JR , Abbott WM , Athanasoulis CA , et al. The diagnosis of deep venous thrombosis in the outpatients by venography. Surg Gynecol Obstet 1980;150:69.

21.

Girolami A. , Simioni P. , Marchiori A. , et al. A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca+ +. Br J Haematol 1993;85:521.

22.

Girolami A. , Marafioti F. , Rubertelli M. , et al. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. Acta Haematol 1986;75:54.

23.

Girolami A. , Marafioti F. , Rubertelli M. , et al. Antithrombin III Trento. A "new" congenital antithrombin III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. Acta Haematol 1984;72:71.

24.

Exner T. , Triplett DA , Tabener D. , et al. Guidelines for testing and revised criteria for lupus anticoagulants . Thromb Haemost 1991 ;65:320.

25.

Alving BM , Baldwin PE , Richards RL , et al. The dilute phospholipid aPTT: a sensitive assay for verification of lupus anticoagulant. Thromb Haemost 1985 ;54:709.

26.

Triplett DA , Brandt JT , Kaczor D. , et al. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983 ;79:678.

27.

Triplett DA , Barna LK , Unger GA , et al. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993;70:787.

28.

Harris EN , Gharavi AE , Patel SP , et al. Evaluation of the anticardiolipin test in International Workshop 4 April 1986. Clin Exp Immunol 1987;68:215.

29.

Bick RL Disorders of hemostasis and thrombosis. Principles of clinical practice . New York: Thieme, 1985:288.

30.

Bick RL , Jakway J. , Baker W. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemost 1992;18(2):267.

31.

Long AA , Ginsberg J. , Brill-Edwards P. , et al. The relationship of antiphospholipid antibodies to thromboembolic disease in SLE: a cross-sectional study. Thromb Haemost 1991;66:520.

32.

Simioni P. , Zanon E. , Prandoni P. , et al. Lupus anticoagulant and antiphospholipid antibodies in outpatients with clinically suspected DVT. Lupus 1994;3:361.

33.

Derksen Rhwm , de Groot G. , Kater L. , et al. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993 ;52:689.

34.

Vianna JL , Khamashta MA , Ordi-Ros J. , et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicentre Study of 114 patients. Am J Med 1994;96:3.

35.

Heijber H. , Brandjes Dpm , Buller HR , et al. Deficiencies of coagulation-inhibition and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 1990:323:1512.